Merck KGaA kjøper Bio-Techne for 11,3 milliarder dollar

104 sources
bloomberg.com
  • Merck KGaA har inngått avtale om å kjøpe Bio-Techne for 73 dollar per aksje i kontanter, en premie på omtrent 36 % over nylige handelsnivåer, ifølge selskapene.
  • Avtalen på 11,3 milliarder dollar legger Bio-Technes reagenser, proteiner og instrumenter til Mercks MilliporeSigma-divisjon, noe som utvider en aggressiv M&A-strategi under administrerende direktør Kai Beckmann.
  • Aktivistinvestoren Ananym Capital Management hadde bare dager tidligere oppfordret Bio-Technes styre til å vurdere et salg, med argumentet om at selskapet «ødela verdi» som en selvstendig enhet.
Sources (104)
  1. 1 默克 KGaA 提出的收购价较Bio-Techne一个月成交量加权平均价溢价36% finance.sina.cn
  2. 2 Merck agrees $3.9 billion takeover of SpringWorks - pharmaphorum pharmaphorum.com
  3. 3 Germany's Merck eyes life science deals, but muted 2026 ... www.itiger.com
  4. 4 Merck KGaA Is Looking for Deals With €20 Billion War Chest news.bloomberglaw.com
  5. 5 Activist Investor Ananym Urges Bio-Techne to Consider Selling www.bloomberg.com
  6. 6 Acquisitions and Divestments - Investors - Merck Group www.merckgroup.com
  7. 7 Bio-Techne (TECH) News Today - MarketBeat www.marketbeat.com
  8. 8 Bio-Techne Corporation Stock Price: Quote, Forecast, Splits & News ... www.perplexity.ai
  9. 9 Bio-Techne misses revenue estimates as US academic funding cuts ... www.reuters.com
  10. 10 User markets.chroniclejournal.com
  11. 11 Activist Investor Ananym Capital Urges Bio-Techne To Explore Sale Options www.nasdaq.com
  12. 12 Merck KGaA. (8/1/24). "Press Release: Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering". Darmstadt. www.life-sciences-usa.com
  13. 13 Merck KGaA Predicts Slightly Better Profit as New CEO Takes Over www.bloomberg.com
  14. 14 Bio-Techne Releases Third Quarter Fiscal 2026 Results investors.bio-techne.com
  15. 15 [PDF] 10-Q - 02/04/2026 - Bio-Techne investors.bio-techne.com
  16. 16 News releases www.merck.com
  17. 17 SEC filings - Merck.com www.merck.com
  18. 18 Merck boosts cancer portfolio with $6.7 billion buyout of Terns Pharma www.reuters.com
  19. 19 bio-techne corporation investors.bio-techne.com
  20. 20 Biotech M&A Tracker 2026 — Updated Daily - BioBucks www.biobucks.co
  21. 21 Merck Delivers Solid Start to the Year and Upgrades Full-Year ... www.merckgroup.com
  22. 22 Merck KGaA News | The Pharmaletter www.thepharmaletter.com
  23. 23 Bio-Techne (TECH) Research Report - StockStory stockstory.org
  24. 24 Acquisitions and Divestments - Investors | Merck KGaA, Darmstadt ... www.emdgroup.com
  25. 25 Merck Stock Price Today | ETR: MRCG Live - Investing.com www.investing.com
  26. 26 Asuragen awaits results of $320m Bio-Techne acquisition - globalventuring.com
  27. 27 [PDF] BIO-TECHNE CORPORATION investors.bio-techne.com
  28. 28 tech20190630_10k.htm - Bio-Techne investors.bio-techne.com
  29. 29 Merck KGaA, MRK:BRN summary markets.ft.com
  30. 30 Is Merck KGaA's $6 billion bid for Millipore too costly? www.reuters.com
  31. 31 Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns ... www.swissquote.com
  32. 32 Merck KGaA to buy biotech SpringWorks for $3.9B | BioPharma Dive www.biopharmadive.com
  33. 33 Merck KGaA: Definitive Agreement Signed Today - Moomoo www.moomoo.com
  34. 34 Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma ... www.drugdiscoverynews.com
  35. 35 Your Request Originates from an Undeclared Automated Tool www.sec.gov
  36. 36 investment - [LSG] Life-Sciences-Germany.com www.life-sciences-germany.com
  37. 37 exv99w1 - SEC.gov www.sec.gov
  38. 38 [PDF] 0001437749-16-038182.pdf - Bio-Techne investors.bio-techne.com
  39. 39 Merck KGaA goes hostile in $5.9 billion Versum takeover battle By Reuters uk.investing.com
  40. 40 Merger and Acquisition (M&A) Deals in Pharmaceuticals ... www.researchandmarkets.com
  41. 41 EX-99.7 - SEC.gov www.sec.gov
  42. 42 List of biotech, pharma & medical device company acquisitions biopharmguy.com
  43. 43 Merck Buys Biotech Co. Millipore for $6B - CBS News www.cbsnews.com
  44. 44 Case No COMP/M.7435 - MERCK/ SIGMA-ALDRICH ec.europa.eu
  45. 45 Anti Cathepsin B Market to Witness Stunning Growth 2026-2033 With Merck KGaA, Bio-Techne, BioVision Inc, Santa Cruz Biotechnology www.openpr.com
  46. 46 Major deals involving US drugmakers and biotechs over the past ... www.reuters.com
  47. 47 Acquisitions (Tables) - Bio-Techne investors.bio-techne.com
  48. 48 MERCK CLOSES IN ON $6BN BIOTECH ACQUISITION TO ... intellectia.ai
  49. 49 [PDF] Proxy Statement - Bio-Techne investors.bio-techne.com
  50. 50 tech20200518_8k.htm investors.bio-techne.com
  51. 51 Acquisitions, Research Collaborations and Licensing Agreements www.sec.gov
  52. 52 XBRL Viewer - SEC.gov www.sec.gov
  53. 53 Bio-Techne beats quarterly estimates, flags tariff uncertainty for ... www.reuters.com
  54. 54 Bio-Techne to acquire Quad Technologies - analytica-world.com www.analytica-world.com
  55. 55 Merck steigt bei Biotechfirma Saturnus ein www.reuters.com
  56. 56 Merck KGaA, Dr. Reddy's in biosimilars deal www.reuters.com
  57. 57 Merck KGaA in move to expand range of MS drugs www.reuters.com
  58. 58 Reuters | Breaking International News & Views www.reuters.com
  59. 59 Events & presentations - Merck.com www.merck.com
  60. 60 GSK pays up to $4.2 billion for Merck KGaA cancer immunotherapy www.reuters.com
  61. 61 Acquisitions and divestments - Merck KGaA, Darmstadt, GermanyMerck KGaA, Darmstadt, Germany Annual Report 2024 www.reports.emdgroup.com
  62. 62 Merck in talks to buy biotech Revolution Medicines, FT reports www.reuters.com
  63. 63 2025-04-28 Merck to Acquire US Biopharma Company SpringWorks ... www.merckgroup.com
  64. 64 Merck KGaA sets details of 2 bln euro capital rise www.reuters.com
  65. 65 Bio-Techne Corporation Completed its Acquisition of Advanced Cell ... investors.bio-techne.com
  66. 66 Section 16 Filings :: Bio-Techne Corporation (TECH) investors.bio-techne.com
  67. 67 JPM26: Biotech's M&A lift, the 'new' Biogen and Merck's $70B target www.biopharmadive.com
  68. 68 Bio-Techne Declares Dividend :: Bio-Techne Corporation (TECH) investors.bio-techne.com
  69. 69 Acquisitions - Bio-Techne investors.bio-techne.com
  70. 70 [PDF] Bio-Techne Corporation investors.bio-techne.com
  71. 71 Bio-Techne (TECH) Gains 4% as Activist Investor Pushes for Strat www.gurufocus.com
  72. 72 Activist Investor Ananym Urges Bio-Techne to Consider a Sale www.insidearbitrage.com
  73. 73 Bio-Techne Releases Third Quarter Fiscal 2026 Results - SEC.gov www.sec.gov
  74. 74 AllMind allmind.ai
  75. 75 Stock Data :: Bio-Techne Corporation (TECH) investors.bio-techne.com
  76. 76 Bio-Techne gains on report activist investor Ananym pushing for sale seekingalpha.com
  77. 77 Merck signs $3bn deal for Kate Bingham-backed eye disease biotech www.ft.com
  78. 78 Merck bid for Japanese chip materials maker triggers state-backed fund deal www.ft.com
  79. 79 HTML - Bio-Techne investors.bio-techne.com
  80. 80 Press Releases - Bio-Techne investors.bio-techne.com
  81. 81 Bio-Techne to acquire Advanced Cell Diagnostics for $250 mln www.reuters.com
  82. 82 tech20160706_8k.htm investors.bio-techne.com
  83. 83 Germany's Merck to buy US biotech SpringWorks for $3.9bn www.ft.com
  84. 84 Merck in $700 million schizophrenia deal www.reuters.com
  85. 85 Breakingviews - Tax steroids justify Bayer's $14 bln Merck deal www.reuters.com
  86. 86 Bio-Techne Corp $TECH Shares Acquired by Tema Etfs LLC www.marketbeat.com
  87. 87 Bio-Techne Corporation (TECH) Stock Price, News, Quote & History finance.yahoo.com
  88. 88 Why Bio-Techne (TECH) Stock Is Trading Up Today finance.yahoo.com
  89. 89 Life Science Company News, Pharma, Biotechnology, Medical ... www.biospectrumasia.com
  90. 90 Trade Bio-Techne (TECH) Stock After-hours on Public.com public.com
  91. 91 News > Europe - The Mass Spectrometry Web Portal www.mass-spec-capital.com
  92. 92 Bio-Techne (TECH) Stock Price, News & Analysis - MarketBeat www.marketbeat.com
  93. 93 Buy & Sell BIO-TECHNE Corp (TECH) - Stocks - Pluang pluang.com
  94. 94 8-K - SEC.gov www.sec.gov
  95. 95 TECH*: Bio-Techne Corp Stock Price Quote - BIVA - Bloomberg www.bloomberg.com
  96. 96 Merck KGaA - Company Profile and News www.bloomberg.com
  97. 97 Merck KGaA to buy gene therapy tools maker for $600M finance.yahoo.com
  98. 98 New EMD Millipore Reportedly the Third Largest Investor in Life ... www.genengnews.com
  99. 99 Merck in Talks to Buy Biotech Revolution Medicines, FT Says www.bloomberg.com
  100. 100 Merck Wants to Do More Multi Tens of Billion-Dollar Deals www.bloomberg.com
  101. 101 Merck KGaA Buys Mirus Bio for $600 Million www.marketscreener.com
  102. 102 Drugmakers Forced to Pay Up for R&D Neglect www.bloomberg.com
  103. 103 Merck builds in cell, gene therapies with Mirus Bio deal pharmaphorum.com
  104. 104 Merck KGaA Sees Post-Covid Life Sciences Rebound, Eyes M&A www.bloomberg.com
Tags
Share

Relaterte innlegg

Legg igjen en kommentar

Your email address will not be published. Required fields are marked *